Major Trials On Dual-Antiplatelet Therapy For DES In The Works

The four major drug-eluting stent manufacturers are negotiating the design of a clinical trial that will help determine the optimal duration of concomitant dual-antiplatelet therapy for patients with a drug-eluting stent, according to Boston Scientific